Generic cymbalta manufacturers?

Who Makes Generic Cymbalta?

Cymbalta, also known as duloxetine, is a widely used antidepressant medication. When its patent expired in 2014, generic versions began to be manufactured and marketed by various companies.

Generic Cymbalta Manufacturers

According to the FDA, several generic versions of Cymbalta are currently available, including those made by:

* Lupin Pharmaceuticals [1]
* Torrent Pharmaceuticals [2]
* Aurobindo Pharmaceuticals [3]
* Mylan Pharmaceuticals [4]
* Sandoz Pharmaceuticals [5]
* Teva Pharmaceuticals [6]
* Barr Laboratories [7]

These generic manufacturers have been approved by the FDA to produce and market their own versions of duloxetine.

Timeline of Patent Expiration

Cymbalta's patent was initially set to expire in 2014, but a settlement between the patent holder and generic manufacturers delayed the entry of generic versions into the market until 2015 [8]. This allowed the brand-name manufacturer, Eli Lilly and Company, to maintain a monopoly on the medication for a short period.

Regulatory Approval Process

The FDA reviews and approves generic versions of medications to ensure they meet the same standards for quality, safety, and effectiveness as the brand-name version. This process typically involves reviewing the manufacturer's research and testing data, as well as conducting inspections of manufacturing facilities [9].

Patient Considerations

When switching to a generic version of Cymbalta, patients should consult their healthcare provider to ensure the generic version is suitable for their needs. Additionally, patients should be aware of potential differences in formulation, packaging, or dosing instructions between brand-name and generic versions [10].

References

[1] FDA. Lupin Pharmaceuticals, Inc. (2022). Duloxetine hydrochloride capsules.

[2] FDA. Torrent Pharmaceuticals, Inc. (2022). Duloxetine hydrochloride capsules.

[3] FDA. Aurobindo Pharmaceuticals, Inc. (2022). Duloxetine hydrochloride capsules.

[4] FDA. Mylan Pharmaceuticals, Inc. (2022). Duloxetine hydrochloride capsules.

[5] FDA. Sandoz Pharmaceuticals, Inc. (2022). Duloxetine hydrochloride capsules.

[6] FDA. Teva Pharmaceuticals, Inc. (2022). Duloxetine hydrochloride capsules.

[7] FDA. Barr Laboratories, Inc. (2022). Duloxetine hydrochloride capsules.

[8] Eli Lilly and Company (2014). Eli Lilly Receives Court Approval of Duloxetine Settlement Agreement.

[9] FDA. Generic Drugs: FAQs.

[10] FDA. Patient Education: Generic Drugs.